Zobrazeno 1 - 10
of 22
pro vyhledávání: '"April Jorge"'
Autor:
J Antonio Aviña-Zubieta, John M. Esdaile, Yufei Zheng, Na Lu, April Jorge, Mary A. De Vera, Hyon K. Choi, Natalie McCormick
Publikováno v:
Arthritis Care Res (Hoboken)
Objective Hydroxychloroquine (HCQ) has been associated with improved survival among patients with systemic lupus erythematosus (SLE) from tertiary referral centers. We aimed to determine the potential impact of HCQ use on the risk of mortality among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86fdc754a48b3dbaafb2ab889018eb0
https://europepmc.org/articles/PMC7665987/
https://europepmc.org/articles/PMC7665987/
Autor:
John H. Stone, Reza Zonozi, John L. Niles, Xiaoqing Fu, Hyon K. Choi, Zachary S. Wallace, Yuqing Zhang, Claire Cook, April Jorge, Anushya Jeyabalan
Publikováno v:
Semin Arthritis Rheum
Objective Myocardial infarction and ischemic stroke are leading causes of cardiovascular (CV) morbidity and mortality in ANCA-associated vasculitis (AAV), especially for the 20% with end-stage renal disease (ESRD). We assessed the impact of renal tra
Autor:
Terry K. Means, Samantha Licciardi, April Jorge, Andrew D. Luster, Rachel Kim, Taotao Lao, Joseph El-Khoury, Zaida G. Ramirez-Ortiz
Deficiency in the clearance of cellular debris is a major pathogenic factor in the emergence of autoimmune diseases. We previously demonstrated that mice deficient for scavenger receptor class F member 1 (SCARF1) develop a lupus-like autoimmune disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6da2abaf49a432a25f3a3ea08ee2b962
https://doi.org/10.1101/2021.05.24.445434
https://doi.org/10.1101/2021.05.24.445434
Autor:
April Jorge, Yuqing Zhang, Kristin M. D’Silva, Zachary S. Wallace, Andrew Cohen, Natalie McCormick, Hyon K. Choi
Publikováno v:
Arthritis & Rheumatology
Arthritis Rheumatol
Arthritis Rheumatol
Patients with systemic autoimmune rheumatic diseases (ARDs) continue to be concerned about risks of severe coronavirus disease 2019 (COVID-19) outcomes. This study was undertaken to evaluate the risks of severe outcomes in COVID-19 patients with syst
Autor:
Yuqing Zhang, Kristin M. D’Silva, Natalie McCormick, Zachary S. Wallace, Hyon K. Choi, April Jorge, Andrew Cohen
Publikováno v:
The Lancet Rheumatology
Summary Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes remain a major concern for patients with rheumatic and musculoskeletal diseases. We aimed to investigate temporal trends in COVID-19 outcomes in patients with r
Publikováno v:
Arthritis & Rheumatology. 71:403-410
OBJECTIVE A prior study showed that premature mortality among patients with end-stage renal disease (ESRD) due to lupus nephritis (LN) persisted in the US between 1995 and 2006. The present study was undertaken to extend this analysis through 2014 to
Publikováno v:
Nature Reviews Rheumatology. 14:693-703
Despite advances in therapy for rheumatic diseases, hydroxychloroquine remains almost universally recommended for the treatment of systemic lupus erythematosus (SLE), and is often used in the management of other rheumatic diseases such as rheumatoid
Publikováno v:
The Journal of Rheumatology. 45:1689-1695
Objective.Systemic autoimmune rheumatic diseases (SARD) are associated with an increased risk of premature cardiovascular disease (CVD) and all-cause mortality. We examined the potential survival benefit of statin use among patients with SARD in a ge
Autor:
Deborah S. Collier, Chio Yokose, Sarah F. Keller, Naomi Serling-Boyd, Marcy B. Bolster, Kristin M. D’Silva, Amar Oza, Mark Matza, Hyon K. Choi, April Jorge, Mazen Nasrallah
Publikováno v:
Semin Arthritis Rheum
OBJECTIVE: Achieving goal serum urate levels in patients with gout remains difficult in primary care and rheumatology practices. This study measured the ability of an asynchronous electronic visit (E-visit) program to facilitate achieving a goal seru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c1a5550c16fb73b712f4e15ebb1ce9b
https://europepmc.org/articles/PMC7492421/
https://europepmc.org/articles/PMC7492421/
Autor:
Emma Stevens, April Jorge, Hongshu Guan, Kazuki Yoshida, Candace H. Feldman, Brendan M. Everett, Karen H. Costenbader, Daniel Li, Cameron B. Speyer
Publikováno v:
Rheumatol Int
OBJECTIVE: Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Gar